Skip to main content
HairCited

Copper Peptides (GHK-Cu) ： 男性型・女性型脱毛症（AGA）

D

No studies available.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dcopper\u002Dpeptides\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            D

        

        

            
結論

            
            
No studies available.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
0

        
研究数

    

    

        
--

        
参加者数

    

    

        
            
            ↔
            
        
        
Neutral

    

    

        D

        
グレード

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
一般的な使用量

                

                    
                    

                        
topical:

                        
1-3% GHK-Cu in topical formulations applied daily

                    

                    
                

                
                

                    上限量： Not established for topical use; oral supplementation not recommended
                

                
            

            

            

            
            

                推奨摂取タイミング： Apply topically to clean scalp in the evening; allow 20 minutes before other products
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
報告されている副作用

                    
    
                        
                        
  • 
                            ⚠
                            Scalp irritation or redness with topical use
                        
    • 
                        
                        
  • 
                            ⚠
                            Skin sensitivity in some individuals
                        
    • 
                        
                        
  • 
                            ⚠
                            Copper toxicity risk if ingested orally in large amounts
                        
    • 
                        
                    

                

                

                
                

                    
既知の相互作用

                    
    
                        
                        
  • 
                            ●
                            Other topical actives (minoxidil — may affect absorption timing)
                        
    • 
                        
                        
  • 
                            ●
                            Zinc supplements (zinc and copper compete for absorption if taken orally)
                        
    • 
                        
                        
  • 
                            ●
                            Chelating agents (may bind copper and reduce efficacy)
                        
    • 
                        
                    

                

                

                
                

                    

                        耐容上限摂取量： Not established for topical use; oral supplementation not recommended
                    

                

                
            

            

                サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Copper Peptides (GHK-Cu) help with 男性型・女性型脱毛症（AGA）?
            
        
        

            Based on 0 studies with 0 participants, there is preliminary evidence that needs more research that Copper Peptides (GHK-Cu) may support 男性型・女性型脱毛症（AGA） management. Our evidence grade is D (Very Early Research).
        

    

    
    

        
            How much Copper Peptides (GHK-Cu) should I take for 男性型・女性型脱毛症（AGA）?
            
        
        

            Studies have used various dosages. A commonly studied range is 1-3% GHK-Cu in topical formulations applied daily. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Copper Peptides (GHK-Cu)?
            
        
        

            Reported side effects may include Scalp irritation or redness with topical use, Skin sensitivity in some individuals, Copper toxicity risk if ingested orally in large amounts. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Copper Peptides (GHK-Cu) and 男性型・女性型脱毛症（AGA）?
            
        
        

            We rate the evidence as Grade D (Very Early Research). This rating is based on 0 peer-reviewed studies with 0 total participants. The overall direction of effect is neutral.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
                

                    
Copper Peptides (GHK-Cu) 他の症状・状態について

                    

                        
                        
                            加齢性薄毛
                            D

                        
                        
                    

                

                
            

        

        

    


    
    












    

        FDAに関する免責事項:
        これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。